Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 1

1(16.7%)

Phase 4

1(16.7%)

6Total

N/A(4)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT06377358Not ApplicableCompleted

Study of Lipolysis of Visceral Reserve Fat Using Tecar Therapy.

Role: collaborator

NCT07029061Not ApplicableCompleted

Effect of Air Splints on Sensoriomotor Disturbances of the Affected Upper Extremity and Trunk Control in the Adult Post-stroke Patient

Role: lead

NCT06116539Phase 1Unknown

Use of Cyanoacrylate in Healing and Pain in the Palatal Donor Site of Connective Tissue Grafts

Role: lead

NCT05265494Not ApplicableCompleted

Let´s Talk About Sleep in College Student

Role: collaborator

NCT03696511Not ApplicableUnknown

Miniscrews Primary Stability

Role: collaborator

NCT03633292Phase 4Completed

Aloe Vera and Chlorhexidine Against Traumatic Oral Ulcers

Role: collaborator

All 6 trials loaded